Three test positive for COVID-19 in Mysuru
District Health Officer Kumaraswamy told The Hindu that a total of 78 persons were subjected to tests in the district over the last few days. Of them, three had tested positive for COVID-19, two persons on May 23 and one on Saturday.
'The two persons hailed from K.R. Nagar taluk, and one was from H.D. Kote taluk,' Dr. Kumaraswamy said, adding that all the three cases were 'mild' in nature, and the patients were 'very much recovering'.
The field staff were visiting their houses and sensitising them while taluk health officers were checking on their condition and monitoring them for the severity of the cases.
Though the COVID-19 affecting people now was a 'mild variant', Dr. Kumaraswamy said the Department of Health and Family Welfare in Mysuru had taken all necessary steps to tackle any eventuality. 'There is no need for alarm or panic,' he said.
Presently, the department was conducting RTPCR tests on SARI (Severe Acute Respiratory Infection) cases reported in hospitals and other medical facilities. However, those who are above 60 years of age, people with co-morbidities, and pregnant women have been requested to take precautionary measures.
The RTPCR tests were presently conducted at Mysore Medical College and Research Institute. The testing facility will be revamped to increase the capacity for round the clock testing if such a situation arises, he said.
Minister for Health Dinesh Gundu Rao, who was in Mysuru recently, held a separate meeting with the officials issuing strict instructions on the measures to be taken.
As per the micro-plan drawn up by the authorities, Asha workers and more than 1,000 members of the Village Health, Sanitation, and Nutrition Committees will be spreading awareness about the measures to be taken in rural areas, he added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
4 hours ago
- News18
Breaking India's Non Communicable Diseases Chain: A Call For Freedom From Chronic Diseases
Noncommunicable diseases silently claim millions of Indian lives each year, but with early action, prevention, and awareness, the country can break this deadly chain. Every Independence Day, we drape ourselves in the tricolour, sing the anthem, and remind each other how hard freedom was won. But for millions of Indians living with chronic illnesses, true freedom remains out of reach. Cardiovascular disease, cancer, chronic respiratory illnesses, and diabetes collectively called noncommunicable diseases (NCDs) now account for 62% of all deaths in Southeast Asia, according to the World Health Organization. Every year, nine million people in the region die from these conditions, many before their 70th birthday. Dr Sabine Kapasi, CEO at Enira Consulting, Founder of ROPAN Healthcare, and UN Advisor shares all you need to know: The threat is not only in the staggering numbers, it lies in the way these diseases silently take root. Poor diets, inactivity, pollution, and genetic predisposition create a slow, invisible chain of damage. By the time symptoms are recognised, it is often too late to reverse them. Yet, most premature NCD deaths are preventable. The COVID-19 surge in May 2021 made this painfully clear. Obesity, diabetes, and other chronic conditions sharply increased the risk of death. Thousands who might have survived the virus did not because their bodies were already weakened by diseases they had been silently managing for years. Globally, NCDs claim 41 million lives annually, including 14 million people aged 30 to 70. Without urgent action, the WHO warns this could rise to 55 million by 2030. For India, the stakes are also economic: reports estimate a loss of $4.58 trillion by 2030 due to NCD-related costs, with heart disease and mental health conditions making up the largest share. But there is hope. India's preventive health ecosystem is growing—startups, government programmes, and grassroots health workers are joining forces. Metabolic trackers, Oura Rings, Tata 1mg dashboards, and workplace health screenings are already spotting risks early. If we sustain this momentum, by 2047 we could win freedom from preventable diseases, redefining independence as the ability to live well. The Government's '75/25" initiative aims to bring care to 75 million people with hypertension and diabetes by December 2025. As of March 2025, treatment had reached 42 million people for hypertension and 25 million for diabetes 89% of the target. This progress is encouraging, but numbers alone cannot dismantle stigma, misinformation, or health neglect. Encouragingly, AIIMS Nagpur and UNICEF Maharashtra are now addressing an often-ignored crisis: NCDs in children. The 2019 Comprehensive National Nutrition Survey revealed alarming trends among children as young as five. Experts warn of a growing risk among children aged 5–9 and adolescents aged 10–19, proof that prevention must begin far earlier than we think. The fight against NCDs is no longer a public health issue alone, it is a national movement. Just as we once came together to win our political freedom, we must now unite to secure the freedom to live long, healthy, and fulfilling lives. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
NDTV
4 hours ago
- NDTV
ADHD Medicines Reduce Suicide, Crime Risks In Sweeping Study
Drugs to treat attention deficit hyperactivity disorder were linked to a reduced risk of suicidal behavior, substance misuse and criminality in the first research of its kind. The findings come amid increasing debate around whether ADHD is being over-diagnosed and therefore over-treated with drugs like Ritalin. The research published in the British Medical Journal on Wednesday did not investigate whether patients are being accurately diagnosed, but it does provide evidence supporting medical treatment. ADHD is characterized by difficulties with concentration and impulse control. Roughly 5% of children and 2.5% of adults are estimated to have the condition, which is also associated with an increased risk of substance misuse and self-harm. The researchers wanted to test whether the risk changed with medication. The study design was meant to closely mirror a randomized clinical trial, considered the gold standard of research. The scientists looked at health registry data from almost 150,000 patients newly diagnosed with ADHD in Sweden. At a two-year follow-up, they found that patients taking medicine had a 17% reduction in suicidal behavior and a 15% drop in substance misuse. They also found declines in the risk for criminality and transport accidents. When looking at the recurrence of these behaviors, there were also benefits linked to the medication. While the trial cannot show direct causation and could be confounded by factors such as ADHD severity, it provides doctors with vital evidence showing that drugs can address and reduce important risks, according to one of the authors. "These data should inform clinical guidelines, policies and current debates," said Samuele Cortese, a professor of child and adolescent psychiatry at the University of Southampton. The benefit was greater for patients taking stimulant medications than non-stimulants in the study. Stimulants include drugs like Novartis AG's Ritalin, while non-stimulants include Eli Lilly & Co.'s Strattera. The study results echo other similar conclusions, but "the large sample size, use of a national registry, and more sophisticated analysis give greater confidence in these results that findings aren't explained by something else other than medication use," said Adam Guastella, a clinical psychologist who works at Sydney Children's Hospital at Westmead and the University of Sydney's Brain and Mind Center. He was not involved in the research. Prescriptions in England for ADHD medicines have increased 18% year on year since the Covid-19 pandemic, according to research published in the BMJ Mental Health this year. The surge is believed to be linked to greater awareness of the condition.
Economic Times
5 hours ago
- Economic Times
AI and machine learning: Driving a global tech revolution worth trillions
Artificial Intelligence (AI) and Machine Learning (ML) have transformed from a futuristic vision to the fundamental forces behind the world's major tech-empowered industrial revolution. From financial markets to other industries such as healthcare, retail, and manufacturing, AI and ML are no longer supplementary technologies. They are the engines powering innovation, productivity, and economic growth globally. Artificial intelligence is the most prominent commercial opportunity in the rapidly evolving world, with the potential to contribute $15.7 trillion to the global economy by 2030, as indicated by a recent report by PwC. As per the report published by Grand View Research, machine learning, a subset of AI, is anticipated to expand at a compound annual growth rate (CAGR) of over 36% between 2024 and 2030. Transforming global industries at unprecedented speed AI and ML are having an impact on many industries globally. These technologies are transforming business operations, making them more efficient and allowing data-driven decisions in various business domains. It is changing business models and generating unprecedented innovation globally. How? Healthcare AI-powered diagnostic equipment is leading to an earlier and more accurate diagnosis of diseases such as cancer and heart disease. It is assisting in early disease detection and increasing survival chances considerably. Predictive analytics assists hospitals in determining the patients at risk, lowering the rate of readmission by more than 25%. Artificial intelligence is changing the delivery of healthcare services in developed and developing countries, including drug invention and remote discovery. For example, it was discovered using BenevolentAI's AI platform, which analysed vast biomedical datasets to predict how existing drugs could interact with Covid-19 pathways. The AI suggested Baricitinib as a potential medicine within days, something that traditionally could have taken months, helping accelerate clinical trials and eventual emergency approvals. Finance Fraud detection tools empowered with artificial intelligence monitor billions of transactions in real time, and automated trading algorithms make transactions in a matter of seconds. JPMorgan Chase report points out that over $150 million is saved annually through AI-enabled systems. Global consumer financial services are also being secured, liberalised, and personalised through AI-driven banking services. Retail and e-commerce AI-powered predictive analytics can forecast customer purchasing habits with a predicted 90 percent accuracy. It enables retailers to predict demand and customise inventory to ensure the most sales are made, and reduce wastage of stock. These technologies allow dynamic pricing, filtering product recommendations according to the tastes and preferences of customers, acceleration of order placements, easier shopping experiences, and increased satisfaction among customers in both online and offline stores. Manufacturing AI-enabled predictive maintenance systems help factories by predicting breakdowns of equipment before they actually occur, up to a 60% improvement in equipment lifetime alongwith reduction in downtime. This not only saves millions of operational costs, but also improves worker safety. AI-empowered robotics is also becoming involved in complicated and risky operations, increasing productivity and product quality globally. The global AI market size, valued at $196.6 billion in 2024, is projected to surpass $1.8 trillion by 2030. North America currently leads in adoption, but Asia-Pacific is the fastest-growing region, with investments in AI startups increasing year-on-year. Agriculture AI is also poised to play a pivotal role in addressing global challenges. Climate scientists are leveraging AI to model weather patterns and optimise renewable energy grids, potentially reducing carbon emissions by up to 10% annually (Source: In developing economies, AI is enabling leapfrog growth. Empowering people and boosting economies through the AI & ML revolution While automation raises concerns of job loss, the statistics showcase a clearer picture. World Economic Forum estimations show that by the end of 2025, AI will create 97 million new jobs in fields such as AI engineering, data science, as compared to the 85 million jobs already existing in the market (Source: Artificial intelligence development companies are spending heavily on employee upskilling in response to this change. Google AI training already has more than 3 million learners worldwide, and IBM has committed to skilling up to 30 million people by 2030 globally. " Every technological revolution disrupts the job market, but it also creates new opportunities that didn't exist before, " said Naveen Khanna, CEO of Octal IT Solution, which is a leading mobile app development company. " The AI era is no different, and the winners will be those who adapt fastest. " Navigating the ethics and regulatory guidelines of AI innovation With the faster AI adoption rate, ethical and regulatory systems are taking centre stage. The AI Act of the European Union is projected to become fully operative by 2026. It will establish the first complete regulatory framework for the worldwide use of AI. In the meantime, major economies and nations, are implementing specific policies towards AI and machine learning solutions to make it safer and accountable to innovation. A PwC survey revealed that 94% of organizations accepts that they have implemented or planning to implement AI in their business operations as AI ethics will be critical to building trust with stakeholders. Issues related to biased algorithms of AI, data-related privacy, and transparency still exist, yet widely used responsible AI principles are being adopted by companies. Gartner reports that by 2027, organizations will implement small, task-specific AI models, with usage volume at least 3 times more than those of general-purpose large language models (LLMs). Driving the future: AI and ML as the ultimate game changer The AI and ML will become fundamental to business competitiveness in this decade, as the internet did in earlier periods. Early adopters are already reaping exponential gains, while latecomers risk being left behind. Octal IT Solutions is also committed to providing AI-powered solutions that have delivered up to 45% operational efficiency improvements and 30% cost reductions for enterprises. " AI is no longer about replacing humans; it's about augmenting their capabilities ," said Arun Goyal, MD, Octal IT Solution, one of the leading voices in AI innovation. "This shift is empowering businesses to make better decisions, streamline operations, and open entirely new markets that didn't exist a decade ago." AI and ML are no longer optional; they are the driving forces shaping the next era of global innovation and economic growth. Businesses, industries, and nations that embrace this transformation today will define the competitive landscape of tomorrow. Disclaimer - The above content is non-editorial, and TIL hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.
